GlobeStar Therapeutics Corp — Net Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/9587f3f9-7f92-4397-a789-b91c8568132c/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-1.9M | 2022-10-01 – 2023-09-30 | evidence 0001161697-24-000049 |
| FY 2022 | $-1.5M | 2021-10-01 – 2022-09-30 | evidence 0001161697-23-000049 |
| FY 2021 | $-9.8M | 2020-10-01 – 2021-09-30 | evidence 0001161697-22-000027 |
| FY 2020 | $-541.7k | 2019-10-01 – 2020-09-30 | evidence 0001161697-20-000517 |
| FY 2019 | $-675.1k | 2018-10-01 – 2019-09-30 | evidence 0001185185-19-001771 |
| FY 2018 | $-816.7k | 2017-10-01 – 2018-09-30 | evidence 0001185185-19-000011 |
| FY 2017 | $-1.7M | 2016-10-01 – 2017-09-30 | evidence 0001161697-18-000046 |
| FY 2015 | $-1.1M | 2014-10-01 – 2015-09-30 | evidence 0001161697-16-000635 |
| FY 2014 | $-1.2M | 2013-10-01 – 2014-09-30 | evidence 0001161697-15-000043 |
| FY 2013 | $-945.1k | 2012-10-01 – 2013-09-30 | evidence 0001161697-14-000205 |
| FY 2012 | $-1.1M | 2011-10-01 – 2012-09-30 | evidence 0001161697-13-000174 |
| FY 2011 | $-227.8k | 2010-09-16 – 2012-03-31 | evidence 0001161697-12-000393 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
GlobeStar Therapeutics Corp — all facts · Revenue · Operating Income